TEVA PHARMACEUTICALS

Medication Shortage For ADHD: Urgent FDA/DEA Action Needed, Is Cannabis An Alternative?

Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision

Did George Soros Sell His Stake In Israeli-Based SodaStream Because Of Political Reasons?

Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision

Did George Soros Sell His Stake In Israeli-Based SodaStream Because Of Political Reasons?

Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data

Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins

Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data

Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins

Market Wrap For April 7: Bears In Complete Control As Markets Get Hammered Yet Again

Market Wrap For April 4: Dow Suffers Triple Digit Point Loss, Nasdaq Continues To Underperform

TEVA PHARMACEUTICALS Recent News

Market Wrap For April 1: S&P 500 Hitting New All-Time High Not An April Fools' Joke

Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy

Market Wrap For March 28: Markets Still Positive Despite Giving Up Early Gains

Market Wrap For March 19: Yellen Hints of Higher Rates & Sooner Than Expected End To Taper

Market Wrap For March 14: Ukraine Tension Drag Markets Lower

Market Wrap For March 12: Nasdaq Ends Losing Streak, Dow Mildly Lower

Market Wrap For March 4: Bulls Take Over As Ukraine Fears Dissipate

Market Wrap For February 21: Markets End The Week On A Negative Note

Market Wrap For February 10: Markets Cautious Ahead Of Yellen Testimony

Market Wrap For January 29: Markets Lower on Fed Taper, Emerging Markets Worries

Market Wrap For January 23: Chinese Data, Mixed Earnings Spooking Investors

Market Wrap For January 2: Markets Begin 2014 on Negative Note

Market Wrap For December 27: Markets Quiet Before Weekend

Illumina and Other Bargain Biotech Stocks Worth a Look Now

Amgen Earnings Preview: Strong Earnings Growth Expected

Seven Hot Indian Stocks

Top Performing Health Care Stocks in January

Lazard Upgrades Cubist Pharmaceuticals To Buy, $33 PT

Needham Raises PT On Cubist Pharmaceuticals To $33

Deutsche Bank Reports On Procter & Gamble Partnership With Teva Pharmaceuticals

Teva Pharma (TEVA) - A History of Takeovers